{"id":"W3176158528","doi":"10.1007/s10637-021-01141-2","title":"Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors","year":2021,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre; McGill University; Jewish General Hospital","funders":"Genentech; F. Hoffmann-La Roche","keywords":"Nausea; Vomiting; Pharmacokinetics; Medicine; Dosing; Pharmacodynamics; Adverse effect; Pharmacology; Regimen; Gastroenterology; Antagonist; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005713982,0.0008730527,0.001669465,0.0003533315,0.0003512929,0.000528029,0.0004670066,0.0005220865,0.001710316],"category_scores_gemma":[0.000377122,0.0004266052,0.0005513389,0.0003603179,0.0006134321,0.0004797882,0.0002708363,0.001645496,0.0003857786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006698882,"about_ca_system_score_gemma":0.001010351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007255238,"about_ca_topic_score_gemma":0.001467616,"domain_scores_codex":[0.9997864,0.00007116453,0.00001126069,0.00005991528,0.00002429251,0.0000470223],"domain_scores_gemma":[0.9997451,0.00003081327,0.00004840771,0.00003371979,0.00001677544,0.0001252478],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3302455,0.1099838,0.01665942,0.0007602153,0.001207396,0.0004609338,0.0006833992,0.007387316,0.3388314,0.0008411431,0.004771018,0.1881684],"study_design_scores_gemma":[0.1273602,0.8121195,0.02527314,0.0000262524,0.0004789035,0.000458159,0.00009631618,0.003114962,0.02487104,0.0003290467,0.005834364,0.00003805503],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943981,0.001156061,0.0008252744,0.0001489352,0.00006952338,0.001613543,0.0004691477,0.00006832708,0.001251112],"genre_scores_gemma":[0.9934709,0.0007695301,0.001979788,0.0002519155,0.00006288099,0.001316875,0.0007735645,0.00002089374,0.001353551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001710316,"threshold_uncertainty_score":0.005721629,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01302265640741901,"score_gpt":0.2603217956643449,"score_spread":0.2472991392569259,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}